BridgeMD
New treatment option for Cognitive Load and Task Performance in Rotating Residents
Official title Effect of a Localized ICU AI Teaching Agent on Rotating ICU Residents
ClinicalTrials.gov ID: NCT07692035
What this study is testing
- What it's testing
- This trial is an ongoing single-center, pragmatic, parallel-group randomized controlled superiority trial currently in participant recruiting phase, conducted within intensive care unit teaching wards at Peking Union Medical College Hospital, Beijing, China. The scheduled trial implementation period spans March 2026 to June 2026, aiming to evaluate whether an institution-specific, protocol-bound retrieval-augmented AI educational agent (named ICU-Tutor) can reduce residents' extraneous cognitive load and improve standardized ICU protocol task performance compared with free access to unrestricted commercial general-purpose large language model AI tools during early ICU clinical rotation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40. Healthy volunteers may be eligible.
You may be able to join if
- First-time rotating residents with no prior formal ICU clinical rotation experience
- Scheduled to complete a minimum of 4 consecutive weeks of ICU training
- Able to complete all scheduled assessments at Day 3, Day 7, and Day 14 post-randomization
- Possess basic digital literacy to operate assigned AI tools on standard clinical devices
- Voluntarily provide written informed consent to participate in the trial
You likely can't join if
- Cumulative prior formal ICU clinical experience exceeding 7 calendar days
- Regular daily clinical use of AI tools for medical decision-making in the 3 months preceding enrollment
- Physical or cognitive impairment that prevents completion of trial assessments
- Inability to provide written informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.